| Applebaum, J; Reynolds, S; Knispel, J et al. (1998) Identification of melanoma antigens that are immunogenic in humans and expressed in vivo. J Natl Cancer Inst 90:146-9 |
| Bystryn, J C (1998) Vaccines for melanoma. Design strategies and clinical results. Dermatol Clin 16:269-75 |
| Reynolds, S R; Oratz, R; Shapiro, R L et al. (1997) Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. Int J Cancer 72:972-6 |
| Bystryn, J C; Shapiro, R L; Harris, M et al. (1996) Use of vaccines in treatment of malignant melanoma. Clin Dermatol 14:337-41 |
| Tobin, D J; Bystryn, J C (1996) Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res 9:304-10 |
| Schultz, N; Oratz, R; Chen, D et al. (1995) Effect of DETOX as an adjuvant for melanoma vaccine. Vaccine 13:503-8 |
| Cui, J; Chen, D; Misfeldt, M L et al. (1995) Antimelanoma antibodies in swine with spontaneously regressing melanoma. Pigment Cell Res 8:60-3 |
